Filing Details
Jade Biosciences, Inc. (NASDAQ:JBIO) filed a Form 8-K with the Securities and Exchange Commission on June 26, 2026, disclosing a material event.
8k filedNASDAQ:JBIO
Jade Biosciences, Inc. (JBIO) Reports Material Event to SEC
Filing Details Jade Biosciences, Inc. (NASDAQ:JBIO) filed a Form 8-K with the Securities and Exchange Commission on June 26, 2026, disclosing a material event. Market Context Jade…
Market Context
Jade Biosciences, Inc.'s stock currently trades at $22.00 with a market capitalization of $484.2M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Jade Biosciences, Inc.'s stock.
All SEC filings for Jade Biosciences, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View JBIO Stock Page
Frequently Asked Questions
Where can I read JBIO's SEC filings?
Browse all filings on our JBIO SEC filings page.
What types of SEC filings does Jade Biosciences, Inc. file?
Public companies like Jade Biosciences, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.